Access Bio Inc

950130

Company Profile

  • Business description

    Access Bio Inc is a United States based bio company engaged in the research, development, and manufacturing of in vitro rapid diagnostic tests, biosensor, and molecular diagnostic products. The products are for the prevention and early diagnosis of infectious diseases. The company's core in vitro-diagnostic technology includes immunochemical, biochemical and molecular products. The company offers products for Rapid Diagnostic Tests including CareStart G6PD RDT, CareStart Malaria, CareStart Dengue Combo, and CareStart Scrub Typhus IgM; Biosensors product includes CareStart G6PD Biosensor, and Molecular Diagnostics products include CareStart HPV and CareStart CAH.

  • Contact

    65 Clyde Road
    Suite A
    SomersetNJ08873
    USA

    T: +1 732 873-4040

    E: [email protected]

    https://www.accessbio.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    79

Stocks News & Analysis

stocks

Wide moat share expects luck to turn

A tough year for jackpots however earnings are expected to normalise.
stocks

ASX share’s growth story intact despite supply constraints

Short term supply challenges but Chinese growth story remains intact.
stocks

ASX healthcare giant rallies despite a fall in profits

Easing investor concerns and signalling a return to growth.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,269.7013.70-0.15%
CAC 408,475.6622.570.27%
DAX 4026,090.51107.470.41%
Dow JONES (US)52,759.21703.84-1.32%
FTSE 10010,779.3531.190.29%
HKSE26,009.46310.971.21%
NASDAQ26,067.17263.92-1.00%
Nikkei 22566,016.36200.43-0.30%
NZX 50 Index13,972.6652.840.38%
S&P 5007,641.160.000.00%
S&P/ASX 2009,058.906.90-0.08%
SSE Composite Index3,905.201.480.04%

Market Movers